1050331

Takeda Pharamaceutical Company Limited — FEI 3011999558

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 10, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Longmont, CO (United States)